Page last updated: 2024-12-06

oxovanadium iv

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

oxovanadium IV: forms complexes with simple sugars [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID34008
CHEBI ID30046
MeSH IDM0203978

Synonyms (13)

Synonym
oxidovanadium(2+)
[vo](2+)
oxovanadium(iv)
CHEBI:30046
vo(2+)
oxovanadium(2+)
vanadium(4+) oxide ion
oxovanadium iv
vanadyl ion(2+)
20644-97-7
vanadyl(2+)ions
DTXSID30174682
Q3554446

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"4 μM), while both are less toxic in the dark."( Remarkable photocytotoxicity of curcumin in HeLa cells in visible light and arresting its degradation on oxovanadium(IV) complex formation.
Banerjee, S; Chakravarty, AR; Hussain, A; Khan, I; Kondaiah, P; Prasad, P, 2012
)
0.38
" But, the therapeutic outcome of CDDP therapy is limited due to its adverse effects including myelotoxicity and DNA damage which may lead to the subsequent risk of developing secondary cancer."( An oxovanadium(IV) complex protects murine bone marrow cells against cisplatin-induced myelotoxicity and DNA damage.
Basu, A; Bhattacharjee, A; Bhattacharya, S; Samanta, A, 2017
)
0.46

Bioavailability

ExcerptReferenceRelevance
" Both the DNA binding constants and photo nuclease activities of the complexes follow the order 2 (tmp) > 3 (dpq) > 1 (phen), demonstrating the importance of the binding affinity to biomolecules, which improves the bioavailability of reactive oxygen species."( Oxovanadium(IV) based hypocrellin B complexes with enhanced photodynamic activity.
Hou, YJ; Lei, WH; Sun, Y; Wang, XS; Zhang, BW; Zheng, Y; Zhou, QX, 2012
)
0.38
" Interestingly, VC-IV did not alter the bioavailability and renal accumulation of CDDP in mice."( Ameliorative effect of an oxovanadium (IV) complex against oxidative stress and nephrotoxicity induced by cisplatin.
Basu, A; Bhattacharjee, A; Bhattacharya, S; Hajra, S; Samanta, A, 2017
)
0.46
"Hydroxypyrone derivatives have a good bioavailability in rats and mice and have been used in drug development."( Oxovanadium(IV) Coordination Compounds with Kojic Acid Derivatives in Aqueous Solution.
Alladio, E; Berto, S; Bono, A; Cappai, R; Daniele, PG; Lachowicz, JI; Laurenti, E; Nurchi, VM; Sgarlata, C; Valora, G, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
vanadium oxide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (129)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (4.65)18.2507
2000's58 (44.96)29.6817
2010's62 (48.06)24.3611
2020's3 (2.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.74 (24.57)
Research Supply Index4.91 (2.92)
Research Growth Index5.07 (4.65)
Search Engine Demand Index39.02 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (2.96%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other131 (97.04%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]